Aphthous stomatitis—an overview of aetiopathogenesis and management

Clinical and Experimental Dermatology

Volumn 16, Issue 4, 1991, Pages 235-243

  PORTER, S R ^a   SCULLY, C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BECLOMETASONE DIPROPIONATE; BENZYDAMINE; BETAMETHASONE; CARBENOXOLONE; CHLORHEXIDINE GLUCONATE; COLCHICINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DAPSONE; DISINFECTANT AGENT; ETRETINATE; FLUCINONIDE; FLUMETASONE PIVALATE; HYDROCORTISONE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; LEVAMISOLE; TETRACYCLINE; THALIDOMIDE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; ZINC SULFATE;

APHTHOUS STOMATITIS; ETIOLOGY; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; THERAPY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTIGENS, CD; CHILD; FEMALE; HUMAN; MALE; MOUTHWASHES; STOMATITIS, APHTHOUS; T-LYMPHOCYTES;

EID: 0025830716     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1991.tb00365.x     Document Type: Article

References (171)

1. The occurrence of recurrent aphthous ulcers in an adult Swedish population
2. Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents
3. Recurrent aphthous ulcers in a mixed Arab community
4. Recurrent aphthous stomatitis: clinical characteristics and evidence for an immunopathogenesis
5. Progress report: oral ulceration and Behçet's syndrome
6. Aphthous ulcers: a review of the literature on etiology, pathogenesis, diagnosis and treatment
7. Recurrent aphthous stomatitis
8. Diseases of the oral mucous membranes
9. Relationship of mechanical trauma to recurrent ulcerative (aphthae) stomatitis
10. Role of mucosal injury in initiating recurrent aphthous stomatitis
11. Remarks on the possibilities of the simultaneous occurrence of hyperkeratosis of the mucous membrane and recurrent aphthae
12. Comparative cytologic studies in patients with recurrent aphthae and leukoplakia
13. Relief of canker sores on resumption of cigarette smoking
14. More observation on relief of aphthous stomatitis on resumption of cigarette smoking
15. The association between smoking and aphthous ulcers
16. Association between recurrent aphthous ulcers and tobacco habits
17. Behcet's disease
18. Human leukocyte antigen in Sweet's syndrome and its relationship to Behçet's disease
19. Cyclic neutropenia: review of clinical manifestations and management
20. Orofacial manifestations in cyclic neutropenia
21. Syndrome of periodic fever, pharyngitis and aphthous stomatitis
22. Periodic fever associated with aphthous stomatitis pharyngitis and cervical adenitis
23. Oral ulceration: a diagnostic problem
24. Orofacial manifestations of HIV infection
25. Primary immunodeficiency
26. Recurrent aphthae: treatment with vitamin B12, folic acid and iron
27. Clinical and haematological screening in recurrent aphthae
28. Stomatitis and recurrent oral ulceration: is a full blood screen necessary
29. Haematological features and differentiation of recurrent oral ulceration
30. Serum ferritin in recurrent oral ulceration
31. Screening for haematinic deficiencies in patients with recurrent aphthous stomatitis
32. Clinical and haematological assessment of children with recurrent aphthous stomatitis
33. Haematological status in recurrent aphthous stomatitis compared with other oral disease
34. Serum vitamin B12, folate, and iron levels in recurrent oral ulceration
35. Jejunal mucosal abnormalities in patients with recurrent aphthous ulceration
36. Coeliac disease associated with recurrent aphthae
37. Small‐bowel changes in recurrent ulceration of the mouth
38. The detection of IgA‐reticulin antibodies and their incidence in patients with recurrent aphthae
39. Gluten‐sensitive recurrent aphthous stomatitis
40. Food allergy or intolerance in severe recurrent aphthous ulceration of the mouth
41. Canker sores from allergy to weak organic acids (citric and acetic)
42. Food sensitivities, taste changes, aphthous ulcers and atopic symptoms in allergic disease
43. Hypersensitivity reactions in mucous membranes. 1. The statistical relationship between hypersensitivity diseases and recurrent oral ulcerations
44. Effects of suspected foodstuff challenging agents in the etiology of recurrent aphthous stomatitis
45. Food allergens and basophil histamine release in recurrent aphthous stomatitis
46. The use of an elimination diet in the treatment of recurrent aphthous ulceration of the oral cavity
47. Recurrent aphthous ulceration of the mouth
48. The patient with recurrent aphthous ulcers and the patient with herpes labialis: a study of two population samples
49. An epidemiological study of factors associated with recurrent aphthae in women
50. Anxiety levels in recurrent aphthous stomatitis (RAS) patients
51. Psychologic stress and recurrent aphthous ulceration
52. Recurrent Mikulicz's oral aphthae—their relationship to the menstrual cycle
53. Recurrent herpes labialis recurrent aphthous ulcers, and the menstrual cycle
54. Inheritance of aphthous ulcers of the mouth
55. Epidemiological aspects of recurrent aphthous ulcerations
56. Inheritance patterns in recurrent aphthous ulcers: twin and pedigree data
57. No deviations of HLA A and B antigens in patients with recurrent aphthous stomatitis
58. HL‐A histocompatibility antigens in recurrent aphthous ulceration
59. HLA antigens in recurrent oral ulcerations
60. The relationship of HLA‐B and DR phenotypes to Behçet's syndrome, recurrent oral ulceration and the class of immune complexes
61. Immunogenetic markers and immune response in patients with recurrent oral ulceration
62. HLA antigens in recurrent oral ulceration: evidence against a common disease spectrum with Behçet's syndrome
63. HLA‐A, B, C and DR antigens in recurrent oral ulcers
64. HLA‐A, B, C, DR, MT and MB antigens in recurrent aphthous stomatitis
65. Lymphoproliferative responses induced by streptococcal antigens in recurrent aphthous stomatitis and Behçet's syndrome
66. Serum antibody responses to indigenous oral mucosal antigens and selected laboratory‐maintained bacteria in recurrent aphthous ulceration
67. L‐form of bacteria isolated from recurrent aphthous stomatitis lesions
68. 3HOT from recurrent aphthous ulceration
69. A leucocyte migration study on the cell‐mediated immunity against adult human oral mucosa and streptococcal antigens in patients with recurrent aphthous stomatitis
70. Streptococcus sanguis in the pathogenesis of recurrent aphthous stomatitis
71. Humoral responses and cross reactivity to oral streptococci in recurrent aphthous ulceration
72. Leukocyte migration inhibition in recurrent aphthous ulceration
73. Lymphocyte function in recurrent aphthous ulceration
74. Possibility of a viral etiology in recurrent aphthous ulcers and Behçet's syndrome
75. Immunofluorescent studies on circulating lymphocytes in oral mucosal diseases
76. Adenovirus isolation from recurrent oral ulcers
77. Aetiologie and prophylaxe der rezidivierenden Aphthen
78. Varicella zoster virus and recurrent aphthous ulceration
79. Detection of RNA complimentary to herpes simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers
80. Herpes simplex virus not the etiologic agent of recurrent stomatitis
81. Chronic aphthous stomatitis, herpes labialis and related conditions
82. Fluorescent antibody study of herpes simplex virus lesions and recurrent aphthae
83. Recurrent “fever blister” and “canker sore”. Tests for herpes simplex and other viruses with mammalian cell cultures
84. Lack of effect of oral acyclovir on prevention of aphthous stomatitis
85. T lymphocyte subset changes in recurrent aphthous stomatitis
86. Expression of class I and class II major histocompatibility complex antigens on epithelial cells in recurrent aphthous stomatitis
87. Immunohistology of oral lesions from patients with recurrent oral ulcers and Behçet's syndrome
88. Electron microscope study on the pathogenesis of recurrent aphthous ulceration as compared to Behçet's syndrome
89. Possible role of apoptotic cells of the oral epithelium in the pathogenesis of aphthous ulceration
90. Failure of autologous oral epithelia to active RAS lymphocytes
91. Antibody‐dependent cellular cytotoxicity in recurrent aphthous ulceration
92. Cryoglobulins in Behçet's syndrome and recurrent oral ulceration: assay by laser nephelometry
93. Different cross‐reacting circulating immune complexes in Behçet's syndrome and recurrent oral ulcers
94. Circulating soluble immune complexes in recurrent oral ulceration, and Behçet's syndrome
95. Absence of circulating IgG immune complexes in minor recurrent aphthous ulceration
96. Recurrent aphthous stomatitis: an immunofluorescent study
97. Pathomorphologic features of the ulcerative stage of oral aphthous ulceration
98. Immunologische Aspekt in der pathogenese der oralen Aphthosen
99. Serum, salivary and lacrimal immunoglobulins in Behçet's syndrome and oral ulceration
100. IgE and IgD concentrations in patients with recurrent aphthous stomatitis
101. Immunological estimation of blood and saliva in human recurrent oral ulceration
102. Salivary IgA and scrum IgG and IgA in recurrent aphthous stomatitis
103. Studies on recurrent oral aphthae
104. Acute phase proteins and C9 in patients with Behçet's syndrome and aphthous ulcers
105. Acute phase proteins, C9, factor B and lysozyme in recurrent oral ulceration and Behçet's syndrome
106. Serum β2 microglobulin in recurrent aphthous stomatitis and Behçet's syndrome
107. The proportion of suppressor‐inducer T‐lymphocytes is reduced in recurrent aphthous stomatitis
108. Altered T4/T8 ratios in a patient with severe recurrent aphthous ulcers
109. T‐lymphocyte subsets in recurrent aphthous ulceration
110. Alterations of T helper/inducer and T suppressor/inducer cells in patients with recurrent aphthous ulcers
111. A double‐blind trial of systemic zinc sulfate in recurrent aphthous stomatitis
112. Recurrent Mikulicz's aphthae treated with topical hydrocortisone hemisuccinate sodium
113. Triamcinolone acetonide in the treatment of acute and chronic lesions of the oral mucous membranes
114. Recurrent oral Ulceration, A double blind comparison of treatment with Betamethasone valerate aerosol and placebo
115. Betamethasone‐17‐benzoate in the treatment of recurrent aphthous ulcers
116. Bextasol and aphthous ulcers (letter)
117. A controlled clinical trial of efficacy of topically applied fluocinonide in the treatment of recurrent aphthous ulceration
118. Flumethasone pivalate (Locorten) in the treatment of oral diseases
119. Minor aphthous oral ulceration: a double‐blind cross‐over study of Beclomethasone Dipropionate aerosol spray
120. Combination immunosuppressant and topical steroid therapy for treatment of recurrent major aphthae
121. Trial of astringent and antibacterial mouthwashes in the management of recurrent aphthous ulceration
122. Management of recurrent aphthous ulceration–a trial of chlorhexidine gluconate gel
123. Hibitane in the treatment of aphthous ulceration
124. Chlorhexidine gluconate mouthwash in the management of minor aphthous stomatitis
125. Clinical evaluation of benzydamine, chlorhexidine and placebo mouth‐washes in the management of recurrent aphthous stomatitis
126. Effect of chlortetracycline mouthrinses on the healing of recurrent aphthous ulcers: a double blind controlled trial
127. Double‐blind trial of tetracycline in recurrent aphthous ulceration
128. Treatment of recurrent aphthous ulceration of the oral cavity
129. Treatment of recurrent aphthous ulcers with Aureomycin* mouth rinse or Zendium* dentifrice
130. Recurrent aphthous stomatitis; a proposed therapeutic regimen
131. The use of low energy laser therapy to treat aphthous ulcers
132. Effect of Zendium toothpaste on recurrent aphthous stomatitis
133. Treatment of aphthous patients by enhancement of the salivary peroxidase system
134. Double blind crossover trial of levamisole in recurrent aphthous stomatitis
135. Levamisole in aphthous stomatitis: evaluation of three regimens
136. Randomized, double‐blind study of levamisole in recurrent aphthous stomatitis
137. Evaluation of the therapeutic effect of levamisole in treatment of recurrent aphthous stomatitis
138. Double‐blind study of levamisole in aphthous stomatitis
139. Effect of levamisole on the incidence and prevalence of recurrent aphthous stomatitis: a double‐blind clinical trial
140. Double‐blind study of levamisole therapy in recurrent aphthous stomatitis
141. A case report of the successful treatment of recurrent aphthous stomatitis with some preparations of orally administered transfer factor
142. Treatment of severe recurrent aphthous stomatitis with colchicine
143. Treatment of recurrent aphthous stomatitis with gamma globulin: report of five cases
144. Aphthous ulcers responding to etretinate—a case report
145. Topical alpha interferon in the treatment of oral ulcers in Behçet's syndrome: a preliminary report
146. A trial of cromoglycic acid in recurrent aphthous ulceration
147. Di‐sodium cromoglycate in the treatment of recurrent aphthous ulceration
148. Sodium cromoglycate toothpaste in the management of aphthous ulceration
149. Management of recurrent aphthous ulcers: a trial of carbenoxolone sodium mouthwash
150. Dapsone use with oral‐genital ulcers
151. Does phenelzine relieve aphthous ulcers of the mouth
152. Phenelzine in the treatment of aphthous ulcers of the mouth
153. Thalidomide in severe orogenital ulceration
154. Investigation and treatment of orogenital ulceration; studies on a possible mode of action of thalidomide
155. Thalidomide effects in Behçet's Syndrome and pustular vasculitis
156. Thalidomide in the treatment of neuro‐Behçet's syndrome
157. Treatment of Behçet's disease with thalidomide
158. Recurrent aphthous stomatitis of the Behçet's type: Successful treatment with thalidomide
159. Thalidomide, orogenital ulcers and the risk of teratogenesis
160. Significant response of oral aphthosis to thalidomide treatment
161. Thalidomide in the treatment of recurrent, necrotic and giant mucocutaneous aphthae and aphthosis
162. Thalidomide treatment of recurrent necrotic giant mucocutaneous aphthae and aphthosis
163. Treatment of aphthae with thalidomide
164. Crossover study of thalidomide vs placebo in severe recurrent Aphthous Stomatitis
165. Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody
166. Aphthous ulceration of the gastrointestinal tract in patients with the acquired immunodeficiency syndrome (AIDS)
167. Development of polyneuropathy during thalidomide therapy
168. Polyneuropathy after neurosedyn (thalidomide) and its prognosis
169. Thalidamide hypersensitivity in AIDS